BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 16915563)

  • 1. A chip-based miniaturized format for protein-expression profiling: the exploitation of comprehensively produced antibodies.
    Koga H; Kyo M; Usui-Aoki K; Inamori K
    Electrophoresis; 2006 Sep; 27(18):3676-83. PubMed ID: 16915563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel approach to protein expression profiling using antibody microarrays combined with surface plasmon resonance technology.
    Usui-Aoki K; Shimada K; Nagano M; Kawai M; Koga H
    Proteomics; 2005 Jun; 5(9):2396-401. PubMed ID: 15880825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Label-free detection of proteins in crude cell lysate with antibody arrays by a surface plasmon resonance imaging technique.
    Kyo M; Usui-Aoki K; Koga H
    Anal Chem; 2005 Nov; 77(22):7115-21. PubMed ID: 16285656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel antibody microarray format using non-covalent antibody immobilization with chemiluminescent detection.
    Usui-Aoki K; Shimada K; Koga H
    Mol Biosyst; 2007 Jan; 3(1):36-42. PubMed ID: 17216054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplexed sandwich assays in microarray format.
    Nielsen UB; Geierstanger BH
    J Immunol Methods; 2004 Jul; 290(1-2):107-20. PubMed ID: 15261575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of antibody array platforms.
    Haab BB
    Curr Opin Biotechnol; 2006 Aug; 17(4):415-21. PubMed ID: 16837184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of antibodies and microarray coatings as a prerequisite for the generation of optimized antibody microarrays.
    Angenendt P; Glökler J
    Methods Mol Biol; 2004; 264():123-34. PubMed ID: 15020785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a protein chip: a MS-based method for quantitation of protein expression and modification levels using an immunoaffinity approach.
    Warren EN; Elms PJ; Parker CE; Borchers CH
    Anal Chem; 2004 Jul; 76(14):4082-92. PubMed ID: 15253646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved affinity coupling for antibody microarrays: engineering of double-(His)6-tagged single framework recombinant antibody fragments.
    Steinhauer C; Wingren C; Khan F; He M; Taussig MJ; Borrebaeck CA
    Proteomics; 2006 Aug; 6(15):4227-34. PubMed ID: 16826567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface plasmon resonance-enabled mass spectrometry arrays.
    Nedelkov D; Tubbs KA; Nelson RW
    Electrophoresis; 2006 Sep; 27(18):3671-5. PubMed ID: 16915566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ microarray fabrication and analysis using a microfluidic flow cell array integrated with surface plasmon resonance microscopy.
    Liu J; Eddings MA; Miles AR; Bukasov R; Gale BK; Shumaker-Parry JS
    Anal Chem; 2009 Jun; 81(11):4296-301. PubMed ID: 19408947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RCA combined nanoparticle-based optical detection technique for protein microarray: a novel approach.
    Hsu HY; Huang YY
    Biosens Bioelectron; 2004 Jul; 20(1):123-6. PubMed ID: 15142584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in functional protein microarray technology.
    Bertone P; Snyder M
    FEBS J; 2005 Nov; 272(21):5400-11. PubMed ID: 16262682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing recombinant antibody function in SPR immunosensing. The influence of antibody structural format and chip surface chemistry on assay sensitivity.
    Townsend S; Finlay WJ; Hearty S; O'Kennedy R
    Biosens Bioelectron; 2006 Aug; 22(2):268-74. PubMed ID: 16487701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput proteomics using antibody microarrays: an update.
    Borrebaeck CA; Wingren C
    Expert Rev Mol Diagn; 2007 Sep; 7(5):673-86. PubMed ID: 17892372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A biotin label-based antibody array for high-content profiling of protein expression.
    Huang R; Jiang W; Yang J; Mao YQ; Zhang Y; Yang W; Yang D; Burkholder B; Huang RF; Huang RP
    Cancer Genomics Proteomics; 2010; 7(3):129-41. PubMed ID: 20551245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pegylated, steptavidin-conjugated quantum dots are effective detection elements for reverse-phase protein microarrays.
    Geho D; Lahar N; Gurnani P; Huebschman M; Herrmann P; Espina V; Shi A; Wulfkuhle J; Garner H; Petricoin E; Liotta LA; Rosenblatt KP
    Bioconjug Chem; 2005; 16(3):559-66. PubMed ID: 15898722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody microarrays as an experimental platform for the analysis of signal transduction networks.
    Korf U; Henjes F; Schmidt C; Tresch A; Mannsperger H; Löbke C; Beissbarth T; Poustka A
    Adv Biochem Eng Biotechnol; 2008; 110():153-75. PubMed ID: 18528667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-protein interactions and selection: array-based techniques for screening disease-associated biomarkers in predictive/early diagnosis.
    Tomizaki KY; Usui K; Mihara H
    FEBS J; 2010 May; 277(9):1996-2005. PubMed ID: 20412053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A protein microarray ELISA for screening biological fluids.
    Varnum SM; Woodbury RL; Zangar RC
    Methods Mol Biol; 2004; 264():161-72. PubMed ID: 15020788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.